This topic contains a solution. Click here to go to the answer

Author Question: Actively transporting electrolytes from an area of higher concentration to an area of lower ... (Read 46 times)

tth

  • Hero Member
  • *****
  • Posts: 579
Actively transporting electrolytes from an area of higher concentration to an area of lower concentration requires:
 
  a. hydrostatic pressure.
  b. osmotic pressure.
  c. blood pressure.
  d. pulse pressure.

Question 2

The pain relief intervention that stimulates large cutaneous nerve fibers to close the gate is the _________ unit.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

A
Electrolytes are moved by hydrostatic pressure, which is a form of active transport.

Answer to Question 2

TENS
transcutaneous electrical nerve stimulator
TENS stimulates cutaneous nerve fibers with electrical impulses, which follow the same spinal pathway as do pain impulses. The cutaneous nerves close the gate to the pain impulses.




tth

  • Member
  • Posts: 579
Reply 2 on: Jul 11, 2018
:D TYSM


carojassy25

  • Member
  • Posts: 299
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library